Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer
Open Access
- 17 July 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (29) , 27008-27022
Abstract
Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancer Cysteine cathepsin activity suppresses osteoclastogenesis of myeloid-derived suppressor cells in breast cancerKeywords
This publication has 50 references indexed in Scilit:
- Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signalingThe FASEB Journal, 2013
- A Nonpeptidic Cathepsin S Activity-Based Probe for Noninvasive Optical Imaging of Tumor-Associated MacrophagesChemistry & Biology, 2012
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- Cathepsin B Inhibition Limits Bone Metastasis in Breast CancerCancer Research, 2012
- VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast ProgenitorsCancer Cell, 2011
- Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probesCurrent Opinion in Chemical Biology, 2011
- Characterization of the MDSC Proteome Associated with Metastatic Murine Mammary Tumors Using Label-Free Mass Spectrometry and Shotgun ProteomicsPLOS ONE, 2011
- IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasionGenes & Development, 2010
- Development of Near-Infrared Fluorophore (NIRF)-Labeled Activity-Based Probes for in Vivo Imaging of LegumainACS Chemical Biology, 2009
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008